Systems Biology of Early Atopy

Status: Recruiting
Location: See all (12) locations...
Study Type: Observational
SUMMARY

Objectives: * To study the role and interrelationships of established and novel clinical, environmental, biological, and genetic prenatal and early-life factors in the development and course of allergic diseases through age 3 years (or 6 years for those who choose to continue participation into SUNBEAM II), with an emphasis on atopic dermatitis and food allergy * To apply systems biology to identify mechanisms and biomarkers underlying the development of food allergy, atopic dermatitis, and their endotypes * To collect, process, and assay or store environmental and biological samples for current and future use in the study of allergic disease development

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

⁃ Pregnant Women-

⁃ Pregnant women who meet all of the following criteria are eligible for enrollment as study participants:

• Age 18 years or older

• Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent

• Pregnant at any stage

• Planning to give birth at a study-site designated center

• Agrees to enroll offspring into the study at birth

• In the case of multiple gestation, agrees to enroll only one child who will be selected by randomized birth order

⁃ Biological Fathers-

⁃ Biological fathers who meet all of the following criteria are eligible for enrollment as study participants:

• Age 18 years or older

• Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent

Locations
United States
Arkansas
Arkansas Children's Hospital
RECRUITING
Little Rock
California
Sean N. Parker Center for Allergy & Asthma Research at Stanford University
ACTIVE_NOT_RECRUITING
Stanford
Colorado
National Jewish Health
RECRUITING
Denver
Massachusetts
Massachusetts General Hospital, Translational and Clinical Research Center
ACTIVE_NOT_RECRUITING
Boston
Maryland
Johns Hopkins Children's Center, Department of Allergy & Immunology
RECRUITING
Baltimore
Michigan
Henry Ford Health System, Division of Allergy and Immunology
ACTIVE_NOT_RECRUITING
Detroit
North Carolina
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology
ACTIVE_NOT_RECRUITING
Chapel Hill
New York
Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Ohio
Cincinnati Children's Hospital Medical Center
RECRUITING
Cincinnati
Tennessee
Vanderbilt University Medical Center Department of Pediatrics Division of Pediatric Allergy, Immunology, and Pulmonary Medicine
ACTIVE_NOT_RECRUITING
Nashville
Texas
Texas Children's Hospital
RECRUITING
Houston
Wisconsin
University of Wisconsin School of Medicine and Public Health
ACTIVE_NOT_RECRUITING
Madison
Time Frame
Start Date: 2021-03-18
Estimated Completion Date: 2032-03
Participants
Target number of participants: 2500
Related Therapeutic Areas
Sponsors
Collaborators: Rho Federal Systems Division, Inc., Consortium for Food Allergy Research
Leads: National Institute of Allergy and Infectious Diseases (NIAID)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials